Study of Pembrolizumab and Cabozantinib in Patients With Metastatic Renal Cell Carcinoma
Clinical trial NCT03149822 · COMPLETED
Trial details
- NCT number
- NCT03149822
- Sponsor
- University of Colorado, Denver
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-28
- Primary completion
- 2022-12-14
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.